NASDAQ:VVOS

Vivos Therapeutics Stock Insider Trading

etoro logo Buy VVOS
*Your capital is at risk
$2.39
+0.0500 (+2.14%)
At Close: Nov 17, 2025

Vivos Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 17.09M and sold 0 VVOS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 17.09M shares
Sell 0 shares
100% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 09, 2025
Buy
Common Stock
Skaff Michael C
10 Percent Owner
10% Owner 0
Value: $0
Jun 09, 2025
Buy
Common Stock
Skaff Michael C
10 Percent Owner
10% Owner 0
Value: $0
Jun 09, 2025
Buy
Common Stock Purchase Warrant
Skaff Michael C
10 Percent Owner
10% Owner 2 329 886
Value: $5.20M
Jun 09, 2025
Buy
Pre-Funded Warrant
Skaff Michael C
10 Percent Owner
10% Owner 725 258
Value: $73
Jun 09, 2025
Buy
Common Stock
Skaff Michael C
10 Percent Owner
10% Owner 0
Value: $0
Jun 09, 2025
Buy
Common Stock
Skaff Michael C
10 Percent Owner
10% Owner 0
Value: $0
Jun 09, 2025
Buy
Common Stock Purchase Warrant
Skaff Michael C
10 Percent Owner
10% Owner 2 329 886
Value: $5.20M
Jun 09, 2025
Buy
Pre-Funded Warrant
Skaff Michael C
10 Percent Owner
10% Owner 725 258
Value: $73
Nov 26, 2024
Buy
Stock Option (Right to Buy)
A-Award
Huntsman Ronald Kirk
Chief Executive Officer
CEO / President 315 421
Value: $832.7K
Nov 26, 2024
Buy
Stock Option (Right to Buy)
A-Award
Amman Bradford K.
Chief Financial Officer
C-Suite Officer 149 533
Value: $394.8K
Nov 26, 2024
Buy
Stock Option (Right to Buy)
A-Award
Huntsman Ronald Kirk
Chief Executive Officer
CEO / President 315 421
Value: $832.7K
Nov 26, 2024
Buy
Stock Option (Right to Buy)
A-Award
Amman Bradford K.
Chief Financial Officer
C-Suite Officer 149 533
Value: $394.8K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Huntsman Ronald Kirk
Chief Executive Officer
CEO / President 20 000
Value: $47.6K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Sokolow Leonard J
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Thompson Matthew
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Krammer Anja B
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Green Ralph Elias
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Amman Bradford K.
Chief Financial Officer
C-Suite Officer 15 000
Value: $35.7K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Lindsay Mark F.
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Huntsman Ronald Kirk
Chief Executive Officer
CEO / President 20 000
Value: $47.6K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Sokolow Leonard J
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Thompson Matthew
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Krammer Anja B
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Green Ralph Elias
Director
Director 4 000
Value: $10K
Jun 20, 2024
Buy
Stock Option (Right to Buy)
A-Award
Amman Bradford K.
Chief Financial Officer
C-Suite Officer 15 000
Value: $35.7K

About Insider Power

Insider Power is a proprietary algorithm developed by Stockinvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT VIVOS THERAPEUTICS, INC.
Vivos Therapeutics
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening ...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE